Press releases & Latest news
Isofol announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada
GOTHENBURG, Sweden, November 2, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) is pleased…
55 % Overall Response Rate on the safety extension cohorts of the ISO-CC-005 Phase I/IIa study
GOTHENBURG, Sweden, September 30, 2020 – Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today provided an…
Strengthened patent protection for arfolitixorin in Japan
GOTHENBURG, Sweden, September 1, 2020 – Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), has announced today…
Upcoming Events
- November 26, 2020 - November 26, 2020
RedEye: Life Science Day
Isofol will attend at Redeye´s event "Life Science Day" in Stockholm. Isofol´s CEO will be presenting at 11.10 (CET) and the seminar will also be broadcast live. - December 15, 2020 - December 15, 2020
DNB Healthcare Conference 2020
Isofol will participate in this virtual conference hosted by Den Norske Bank. The conference consists of two sessions: DNB Markets Session and DNB NXT Healthcare Venture Session. Isofol will present at 10.15 (CET).